US2003153739A1PendingUtilityA1
Acid sphingomyelinase gene and diagnosis of Niemann-pick disease
Est. expiryMay 3, 2011(expired)· nominal 20-yr term from priority
A01K 2217/05C12N 9/16C12Q 2600/156C12Q 1/6883A61K 38/00C12N 15/8509A01K 2267/0306A01K 2217/00A01K 2227/105C12Q 2600/158A01K 2207/15Y10S435/81A01K 67/0278
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the acid sphingomyelinase gene and to methods of diagnosing Niemann-Pick disease. It is based, at least in part, on the cloning and expression of the full-length cDNA encoding acid sphingomyelinase and on the discovery of mutations in the acid sphingomyelinase gene of Ashkenazi Jewish Niemann-Pick disease patients.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A recombinant nucleic acid molecule encoding a functionally active acid sphingomyelinase gene product.Join the waitlist — get patent alerts
Track US2003153739A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.